OrbusNeich Medical Group Holdings Limited provides earnings guidance for the six months ended June 30, 2023. The Group is expected to record (i) an increase in profit for the period attributable to owners of the Company by over 200% as compared with that for the six months ended June 30, 2022 and (ii) an increase in adjusted profit for the period (non-HKFRS measure Note) by over 100% as compared with that for the Previous Period. The increase in profit for the period attributable to owners of the Company is mainly attributable to the following factors: (i) increase in gross profit arising from the increase in sales of the Group's balloons; (ii) increase in interest income from bank deposits; and (iii) listing expenses did not recur for the Current Period as the listing of the Company was completed in 2022.